ConductScience.org, home

Paper7782019

[The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].

Klimke A and 1 other. Fortschr Neurol Psychiatr, 1995. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. [The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects]. Papers, record 7782019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7782019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].
PubMed
Journal
Fortschr Neurol Psychiatr
PubMed
Year
1995
PubMed
Publication types
English Abstract, Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.85
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klimke AA
2Klieser EE

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ClozapineMajor topic
Psychotic DisordersMajor topic
SchizophreniaMajor topic
Schizophrenic PsychologyMajor topic
Drug Approval
Europe
Humans
Treatment Outcome
United States

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
26243842Effect of Adenine on Clozapine-induced Neutropenia in Patients with Schizophrenia: A Preliminary Study.Clin Psychopharmacol Neurosci2015https://conductscience.org/library/papers/26243842PubMed
18779922Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone.J Neural Transm (Vienna)2008https://conductscience.org/library/papers/18779922PubMed
17109073Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents.J Neural Transm (Vienna)2007https://conductscience.org/library/papers/17109073PubMed
9503276Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.J Neural Transm (Vienna)1997https://conductscience.org/library/papers/9503276PubMed
9063912Rebound insomnia after abrupt clozapine withdrawal.Eur Arch Psychiatry Clin Neurosci1996https://conductscience.org/library/papers/9063912PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7782019

GET https://conductscience.org/api/papers/v1/7782019/authors